DP-b99: Clinical Trials

3 trials of DP-b99, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 31Terminated 1

Follow DP-b99: new trials by email Literature Review of DP-b99 trials Research Report on DP-b99

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DP-b99 in the Treatment of Acute High-risk Pancreatitis
DP-b99, Placebo - Pancreatitis
Phase 2TerminatedD-Pharm Ltd.102013-12-012015-06-23
Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke
DP-b99, Placebo - Acute Ischemic Stroke
Phase 3TerminatedD-Pharm Ltd.4462009-12-012012-10-24
Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke
DP-b99 - Brain Ischemia, Stroke
Phase 2CompletedD-Pharm Ltd.1502005-02-012007-11-26

Conditions studied

Brain Infarction (1)  ·  Brain Ischemia (1)  ·  Cerebrovascular Disorders (1)  ·  Ischemic Stroke (1)  ·  Pancreatitis (1)  ·  Stroke (1)

Sponsors

D-Pharm Ltd. (3)

Countries

Czechia (2)  ·  Germany (2)  ·  Israel (2)  ·  Austria (1)  ·  Brazil (1)  ·  Canada (1)  ·  France (1)  ·  Hungary (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Portugal (1)  ·  Slovakia (1)  ·  South Africa (1)  ·  South Korea (1)

Top investigators

Ashfaq Shuaib, MD (1)  ·  Gilad Rosenberg, M.D. (1)  ·  Gilad Rosenberg, MD (1)  ·  Hugues Chabriat, Prof. (1)  ·  Maria S Rocha, MD (1)  ·  Philippe Lyrer, Prof. Dr. (1)  ·  Tobien Schreuder, MD (1)  ·  Vasco Salgado, MD (1)